Scandinavian Biopharma is a Swedish research-based biotech company located in Solna. They are now developing a vaccine to prevent ETEC, a diarrheal disease that anually affects 400 million people. CEO at Scandinavian Biopharma, Björn Sjöstrand, answers our questions about the project and the vaccine that hopefully will protect travelers from diarrhea and especially save children in developing countries from malnutrition.
Read the full interview with Björn Sjöstrand here (in Swedish) >>
Make sure to follow the project on their upcoming journey at SSCi's Instagram in January.
